A CASE OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED MYOCARDITIS IN NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Murphy, Andrew [1 ]
Ismail, Ali [1 ]
Monzer, Nasser [1 ]
Sangoi, Matthew [1 ]
Khan, Aarish Husain [1 ]
Khazan, Benjamin [1 ]
机构：
[1] Univ Penn Hlth Syst, Penn Hosp, Philadelphia, PA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1260-038
引用
收藏
页码：3191 / 3191
页数：1
相关论文
共 50 条
  • [21] Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients
    Kubo, T.
    Watanabe, H.
    Ninomiya, K.
    Kudo, K.
    Minami, D.
    Murakami, E.
    Ochi, N.
    Ninomiya, T.
    Harada, D.
    Yasugi, M.
    Ichihara, E.
    Ohashi, K.
    Fujiwara, K.
    Hotta, K.
    Tabata, M.
    Maeda, Y.
    Kiura, K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Acute hyponatremia from immune checkpoint inhibitor therapy for non-small cell lung cancer
    Desikan, Sai Prasad
    Varghese, Ron
    Kamoga, Roy
    Desikan, Raman
    POSTGRADUATE MEDICAL JOURNAL, 2020, 96 (1139) : 570 - 571
  • [23] Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients
    Kubo, Toshio
    Watanabe, Hiromi
    Ninomiya, Kiichiro
    Kudo, Kenichiro
    Minami, Daisuke
    Murakami, Etsuko
    Ochi, Nobuaki
    Ninomiya, Takashi
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Ohashi, Kadoaki
    Rai, Kammei
    Fujiwara, Keiichi
    Hotta, Katsuyuki
    Tabata, Masahiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (12) : 1447 - 1453
  • [24] Clinical and laboratory predictors of immune checkpoint inhibitor efficacy in non-small cell lung cancer
    Christopoulos, P.
    Kohlhaeufl, J.
    Bozorgmehr, F.
    Kuon, J.
    Schneider, M.
    Neumann, O.
    Liersch, S.
    Heussel, C.
    Winter, H.
    Herth, F.
    Rieken, S.
    Muley, T.
    Meister, M.
    Bischoff, H.
    Lasitschka, F.
    Stenzinger, A.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
    Hao, Yuxuan
    Zhang, Xiaoye
    Yu, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung Cancer
    Lin, Jessica J.
    Chin, Emily
    Yeap, Beow Y.
    Ferris, Lorin A.
    Kamesan, Vashine
    Lennes, Inga T.
    Sequist, Lecia V.
    Heist, Rebecca S.
    Mino-Kenudson, Mari
    Gainor, Justin F.
    Shaw, Alice T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (01) : 135 - 140
  • [27] Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report
    Taiki Hakozaki
    Yusuke Okuma
    Jumpei Kashima
    BMC Cancer, 18
  • [28] Neoadjuvant Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
    Xue, Chongxiang
    Dong, Huijing
    Chen, Ying
    Lu, Xingyu
    Zheng, Shuyue
    Cui, Huijuan
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (06): : 779 - 788
  • [29] Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report
    Hakozaki, Taiki
    Okuma, Yusuke
    Kashima, Jumpei
    BMC CANCER, 2018, 18
  • [30] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
12345